Allo-HCT in CLL after multiple pathway inhibitors. Group Chronic Malignancies Working Party (CMWP) Principal investigator Michel van Gelder/Olivier Tournilhac
Outcomes following the use of PTCy in URD allo-HCT for CML Group Chronic Malignancies Working Party (CMWP) Principal investigator Guillermo Orti
Autologous Peripheral Blood Stem Cell Mobilisation Techniques, Stem Cell Yields and Practice Variation-By-Country in Patients with Myeloma Undergoing First Autologous Stem Cell Transplants in EBMT Centres. Group Chronic Malignancies Working Party (CMWP) Principal investigator Patrick Hayden
Outcomes of Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) in Patients with CALR-Mutated Myelofibrosis compared to those patients with a JAK2-mutation. Group Chronic Malignancies Working Party (CMWP) Principal investigator Juan Carlos Hernández-Boluda
GvHD Prophylaxis Incorporating Methotrexate in Allo-HCT for Chronic Myeloid Malignancies and sAML: A Retrospective Analysis from the CMWP of the EBMT. Group Chronic Malignancies Working Party (CMWP) Principal investigator Thomas Luft
A Novel Early Relapse Prediction Score Based on Age, ISS and Disease Status at the Time of Transplant in Patients with Newly Diagnosed Multiple Myeloma. A Study of the EBMT Chronic Malignancies Working Party Group Chronic Malignancies Working Party (CMWP) Principal investigator Meral Beksac
Outcomes of chronic neutrophilic leukemia patients who underwent allogeneic hematopoietic cell transplantation: a combined CIBMTR/EBMT analysis Group Chronic Malignancies Working Party (CMWP) Principal investigator Bhagirathbai Dholaria/Aleksandar Radujkovic
Impact of Specific Adverse Cytogenetic Features on Outcomes after Allogeneic Hematopoietic Cell Transplantation in Myelodysplastic Syndrome with Very Poor Risk Cytogenetics: A Study from the Chronic Malignancies Working Party of EBMT Group Chronic Malignancies Working Party (CMWP) Principal investigator Xavier Poiré
MDS ATG versus Post-Cy in unrelated donors Group Chronic Malignancies Working Party (CMWP) Principal investigator Yves Chalandon, Marie Robin
CLL - Projects about PI, ibrutinib and venetoclax Group Chronic Malignancies Working Party (CMWP) Principal investigator Olivier Tournilhac, Michel van Gelder
Non-interventional Study on alloHSCT in 17p- CLL Group Chronic Malignancies Working Party (CMWP) Type of Stem Cell Treatment Principal investigator Johannes Schetelig
MDS after SAA (cooperation with SAA registry) Group Severe Aplastic Anaemia Working Party (SAAWP) Chronic Malignancies Working Party (CMWP) Type of Stem Cell Treatment Principal investigator Jacob Passweg